Target intelligence / Profile preview

Methionine adenosyltransferase II, alpha pseudogene (null)

Target: null
Molecular classification: Other (Pseudogene)

Overview

ENSG00000258012 encodes a pseudogene corresponding to the methionine adenosyltransferase II, alpha (MAT2A) gene. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional; they may arise via gene duplication or retrotransposition and typically do not encode functional proteins[4]. While the canonical MAT2A gene encodes an enzyme that catalyzes S-adenosylmethionine synthesis from methionine and ATP[3][5], the pseudogene variant does not produce an active protein and, therefore, lacks direct biological or pharmacological function.

Mechanism of action

null

Beyond the preview

Go deeper on Methionine adenosyltransferase II, alpha pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methionine adenosyltransferase II, alpha pseudogene (null).

Explore the full profile